AAAAAA

   
Results: 1-17 |
Results: 17
SYNERGY OF ABCIXIMAB AND TICLOPIDINE IN PATIENTS UNDERGOING INTRACORONARY STENTING
Authors: KLEIMAN NS GRAZIADEI N LANCE E MARESH K TAYLOR J HIGGINBOTHAM J EDWARDS A EFFRON MB MASCELLI MA JORDAN RE
Citation: Ns. Kleiman et al., SYNERGY OF ABCIXIMAB AND TICLOPIDINE IN PATIENTS UNDERGOING INTRACORONARY STENTING, Journal of the American College of Cardiology, 31(2), 1998, pp. 238-238
SAFETY OF ABCIXIMAB RETREATMENT - FINAL CLINICAL REPORT OF THE REOPROREADMINISTRATION REGISTRY (R-3)
Authors: TCHENG JE KEREIAKES DJ BRADEN GA LINCOFF AM MASCELLI MA LANGRALL MA DAMARAJU LV SCHANTZ AR BARNATHAN ES EFFRON MB
Citation: Je. Tcheng et al., SAFETY OF ABCIXIMAB RETREATMENT - FINAL CLINICAL REPORT OF THE REOPROREADMINISTRATION REGISTRY (R-3), Circulation, 98(17), 1998, pp. 82-82
ABCIXIMAB AFFORDS EARLY AND SUSTAINED REPERFUSION BY REDUCED-DOSE RETEPLASE IN A PRIMATE MODEL OF SEVERE ARTERIAL INJURY
Authors: JORDAN RE NAKADA MT MASCELLI MA MACE KF NEDELMAN MA BARNATHAN ES WEISMAN HF
Citation: Re. Jordan et al., ABCIXIMAB AFFORDS EARLY AND SUSTAINED REPERFUSION BY REDUCED-DOSE RETEPLASE IN A PRIMATE MODEL OF SEVERE ARTERIAL INJURY, Circulation, 98(17), 1998, pp. 2765-2765
PHARMACODYNAMIC PROFILE OF SHORT-TERM ABCIXIMAB TREATMENT DEMONSTRATES PROLONGED PLATELET INHIBITION WITH GRADUAL RECOVERY FROM GP IIB IIIARECEPTOR BLOCKADE/
Authors: MASCELLI MA LANCE ET DAMARAJU L WAGNER CL WEISMAN HF JORDAN RE
Citation: Ma. Mascelli et al., PHARMACODYNAMIC PROFILE OF SHORT-TERM ABCIXIMAB TREATMENT DEMONSTRATES PROLONGED PLATELET INHIBITION WITH GRADUAL RECOVERY FROM GP IIB IIIARECEPTOR BLOCKADE/, Circulation, 97(17), 1998, pp. 1680-1688
TICLOPIDINE POTENTIATES ABCIXIMABS ABILITY TO INHIBIT ADP-INDUCED PLATELET-AGGREGATION IN-VITRO
Authors: KLEIMAN NS MASCELLI MA GRAZIADEI N MARESH K EDWARDS A BAYSINGER L FISCHER A LANCE E CABOT C JORDAN R
Citation: Ns. Kleiman et al., TICLOPIDINE POTENTIATES ABCIXIMABS ABILITY TO INHIBIT ADP-INDUCED PLATELET-AGGREGATION IN-VITRO, Journal of the American College of Cardiology, 29(2), 1997, pp. 97486-97486
PHARMACODYNAMICS OF REOPRO (C7E3 FAB) - FREE PLASMA-LEVELS DETERMINE CLINICAL EFFICACY
Authors: WAGNER C MACE K MASCELLI MA DERITA R LANCE E WEISMAN H GHRAYEB J JORDAN R
Citation: C. Wagner et al., PHARMACODYNAMICS OF REOPRO (C7E3 FAB) - FREE PLASMA-LEVELS DETERMINE CLINICAL EFFICACY, Thrombosis and haemostasis, 1997, pp. 26-26
IN-VITRO CHARACTERIZATION OF DETHROMBOSIS BY ABCIXIMAB (REOPRO)
Authors: MASCELLI MA MARCINIAK SJ WEISMAN HF JORDAN R
Citation: Ma. Mascelli et al., IN-VITRO CHARACTERIZATION OF DETHROMBOSIS BY ABCIXIMAB (REOPRO), Thrombosis and haemostasis, 1997, pp. 2696-2696
ABCIXIMAB CAUSES PROFOUND, IMMEDIATE INHIBITION OF PLATELET-FUNCTION THAT RECOVERS GRADUALLY AFTER PTCA
Authors: JORDAN RE MASCELLI MA NAKADA MT WEISMAN HF
Citation: Re. Jordan et al., ABCIXIMAB CAUSES PROFOUND, IMMEDIATE INHIBITION OF PLATELET-FUNCTION THAT RECOVERS GRADUALLY AFTER PTCA, Circulation, 96(8), 1997, pp. 4041-4041
RAPID ASSESSMENT OF PLATELET-FUNCTION WITH A MODIFIED WHOLE-BLOOD AGGREGOMETER IN PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY PATIENTS RECEIVING ANTI-GP IIB IIIA THERAPY/
Authors: MASCELLI MA WORLEY S VERIABO NJ LANCE ET MACK S SCHAIBLE T WEISMAN HF JORDAN RE
Citation: Ma. Mascelli et al., RAPID ASSESSMENT OF PLATELET-FUNCTION WITH A MODIFIED WHOLE-BLOOD AGGREGOMETER IN PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY PATIENTS RECEIVING ANTI-GP IIB IIIA THERAPY/, Circulation, 96(11), 1997, pp. 3860-3866
ABCIXIMAB (REOPRO) INHIBITION OF PLATELET-AGGREGATION AND GPIIB-IIIA RECEPTOR DENSITY ARE INDEPENDENT OF P1(A) (HPA-1) GENOTYPE
Authors: COLEMAN L GOLDSCHMIDTCLERMONT PJ LANCE E MASCELLI MA BRAY PF
Citation: L. Coleman et al., ABCIXIMAB (REOPRO) INHIBITION OF PLATELET-AGGREGATION AND GPIIB-IIIA RECEPTOR DENSITY ARE INDEPENDENT OF P1(A) (HPA-1) GENOTYPE, Blood, 90(10), 1997, pp. 3003-3003
RECOVERY OF PLATELET-FUNCTION AFTER REOPRO TREATMENT - GRADUAL TAPERING OF ANTITHROMBOTIC ACTIVITY BUT RAPID RECOVERY OF HEMOSTATIC POTENTIAL
Authors: JORDAN RE NAKADA MT WAGNER CL LANCE ET MASCELLI MA WEISMAN HF
Citation: Re. Jordan et al., RECOVERY OF PLATELET-FUNCTION AFTER REOPRO TREATMENT - GRADUAL TAPERING OF ANTITHROMBOTIC ACTIVITY BUT RAPID RECOVERY OF HEMOSTATIC POTENTIAL, The American journal of cardiology, 80, 1997, pp. 1-1
ABCIXIMAB [7E3] PHARMACODYNAMICS DEMONSTRATES AN EXTENDED AND GRADUALRECOVERY FROM GPIIB IIIA BLOCKADE/
Authors: MASCELLI MA LANCE ET WAGNER CL WEISMAN HF JORDAN RE
Citation: Ma. Mascelli et al., ABCIXIMAB [7E3] PHARMACODYNAMICS DEMONSTRATES AN EXTENDED AND GRADUALRECOVERY FROM GPIIB IIIA BLOCKADE/, Circulation, 94(8), 1996, pp. 3008-3008
ANALYSIS OF GPIIB IIIA RECEPTOR NUMBER BY QUANTIFICATION OF 7E3 BINDING TO HUMAN PLATELETS/
Authors: WAGNER CL MASCELLI MA NEBLOCK DS WEISMAN HF COLLER BS JORDAN RE
Citation: Cl. Wagner et al., ANALYSIS OF GPIIB IIIA RECEPTOR NUMBER BY QUANTIFICATION OF 7E3 BINDING TO HUMAN PLATELETS/, Blood, 88(3), 1996, pp. 907-914
DEFINING THE EFFECTIVENESS OF ANTIPLATETLET THERAPY BY MEASUREMENT OFPLATELET AND PLASMA P-SELECTIN LEVELS
Authors: DALESANDRO MR FREDERICK B GUMBS CI DEUTSCH E FOWLER AB MASCELLI MA JORDAN RE MCCABE RP MCCLAIN LD
Citation: Mr. Dalesandro et al., DEFINING THE EFFECTIVENESS OF ANTIPLATETLET THERAPY BY MEASUREMENT OFPLATELET AND PLASMA P-SELECTIN LEVELS, Blood, 88(10), 1996, pp. 2930-2930
RECRUITMENT OF PREEXISTING ANTI-FAB IMMUNOGLOBULINS TO PLATELETS DOESNOT AFFECT THE SAFETY, PHARMACOKINETICS OR PHARMACODYNAMICS OF REOPRO(TM)
Authors: LANCE E JORDAN B PRESTON A MACE K SCHAIBLE T MASCELLI MA
Citation: E. Lance et al., RECRUITMENT OF PREEXISTING ANTI-FAB IMMUNOGLOBULINS TO PLATELETS DOESNOT AFFECT THE SAFETY, PHARMACOKINETICS OR PHARMACODYNAMICS OF REOPRO(TM), Blood, 86(10), 1995, pp. 3594-3594
HUMAN MONOCLONAL-ANTIBODY HA-1A BINDS TO ENDOTOXIN VIA AN EPITOPE IN THE LIPID-A DOMAIN OF LIPOPOLYSACCHARIDE
Authors: BOGARD WC SIEGEL SA LEONE AO DAMIANO E SHEALY DJ ELY TM FREDERICK B MASCELLI MA SIEGEL RC MACHIELSE B NAVEH D KAPLAN PM DADDONA PE
Citation: Wc. Bogard et al., HUMAN MONOCLONAL-ANTIBODY HA-1A BINDS TO ENDOTOXIN VIA AN EPITOPE IN THE LIPID-A DOMAIN OF LIPOPOLYSACCHARIDE, The Journal of immunology, 150(10), 1993, pp. 4438-4449
REACTIVITY OF THE HUMAN ANTIENDOTOXIN IMMUNOGLOBULIN-M MONOCLONAL-ANTIBODY HA-1A WITH LIPOPOLYSACCHARIDES FROM ROUGH AND SMOOTH GRAM-NEGATIVE ORGANISMS
Authors: MASCELLI MA FREDERICK B ELY T NEBLOCK DS SHEALY DJ PAK KY DADDONA PE
Citation: Ma. Mascelli et al., REACTIVITY OF THE HUMAN ANTIENDOTOXIN IMMUNOGLOBULIN-M MONOCLONAL-ANTIBODY HA-1A WITH LIPOPOLYSACCHARIDES FROM ROUGH AND SMOOTH GRAM-NEGATIVE ORGANISMS, Infection and immunity, 61(5), 1993, pp. 1756-1763
Risultati: 1-17 |